BRECA Male Study: Influences of targeted physical education on treatment side effects in men after breast cancer- a pilot study

BRECA Male Study: Influences of targeted physical education on treatment side effects in men after breast cancer- a pilot study - BRECA Male Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006795

Enrollment

Registered

2017-03-17

Start date

2014-09-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50.9

Interventions

Group 1: Group one is completing a moderate training with 40- 50% of the maximum heart rate for 12 weeks. Week 1-2: 3x/week endurance work outs for 30 minutes. Patients could select which kind of end

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: - Men after Breast Cancer - chemotherapy and radiotherapy to date back six month - medical sport fitness permission - signed consent form - computer with internet access

Exclusion criteria

Exclusion criteria: - metastatic cancer - acute orthopedic or internal diseases

Design outcomes

Primary

Measure	Time frame
Feasibility of the study, adherence of the patients (drop out) . It should be clarified, if patients follow the training instructions (check online diary) and if they are attending the four measuring points for their status recovery (t1: Baseline, t2: 3 months, t3: 4 months, t4: 7 months).	—

Secondary

Measure	Time frame
During all four measuring points (t1: Baseline, t2: 3 months, t3: 4 months, t4: 7 months), these data will be collected: Improvement of physical endurance (Spiroergometry), improvement of life quality (EORTC QLC- C30, BR23), reduction of fatigue syndrome (MFI 20), increase of the activity level (GPAQ and KAS), reduction of erectile dysfunktion (IIEF), reduction of male menopause ailment (AMS), development of a training standard therapy, (improvement of objective and subjective cognition)	—

Measure

Time frame

During all four measuring points (t1: Baseline, t2: 3 months, t3: 4 months, t4: 7 months), these data will be collected: Improvement of physical endurance (Spiroergometry), improvement of life quality (EORTC QLC- C30, BR23), reduction of fatigue syndrome (MFI 20), increase of the activity level (GPAQ and KAS), reduction of erectile dysfunktion (IIEF), reduction of male menopause ailment (AMS), development of a training standard therapy, (improvement of objective and subjective cognition)

—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026